NASDAQ:CTCX - Nasdaq - US1429221039 - Common Stock - Currency: USD
0.24
+0 (+0.46%)
The current stock price of CTCX is 0.24 USD. In the past month the price decreased by -45.45%. In the past year, price decreased by -88.24%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.97 | 357.10B | ||
AMGN | AMGEN INC | 15.29 | 162.72B | ||
GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
NTRA | NATERA INC | N/A | 21.43B | ||
BIIB | BIOGEN INC | 8.54 | 20.49B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.
CARMELL CORP
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 10
Company Website: https://www.carmellrx.com/
Phone: 14128948248
The current stock price of CTCX is 0.24 USD. The price increased by 0.46% in the last trading session.
The exchange symbol of CARMELL CORP is CTCX and it is listed on the Nasdaq exchange.
CTCX stock is listed on the Nasdaq exchange.
CARMELL CORP (CTCX) has a market capitalization of 7.23M USD. This makes CTCX a Nano Cap stock.
CARMELL CORP (CTCX) currently has 10 employees.
CARMELL CORP (CTCX) has a resistance level at 0.27. Check the full technical report for a detailed analysis of CTCX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CTCX does not pay a dividend.
CARMELL CORP (CTCX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.91).
The outstanding short interest for CARMELL CORP (CTCX) is 1.18% of its float. Check the ownership tab for more information on the CTCX short interest.
Over the last trailing twelve months CTCX reported a non-GAAP Earnings per Share(EPS) of -1.91. The EPS decreased by -335.72% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1047.37% | ||
ROE | N/A | ||
Debt/Equity | N/A |